ClinicalTrials.Veeva

Menu

Absorption and Metabolism of Olive Leaf Extract and Its Effect on Vascular Reactivity and Cytokine Concentrations

University of Reading logo

University of Reading

Status

Completed

Conditions

Effect on Cytokine Concentrations
Effect on Vascular Function
Absorption and Metabolism

Treatments

Dietary Supplement: Olive leaf extract capsules

Study type

Interventional

Funder types

Other

Identifiers

NCT01479699
OLE study

Details and patient eligibility

About

The purpose of this study is to determine how olive leaf is absorbed and metabolised and also whether it has any effect on the elasticity of blood vessels and the immune system.

Full description

The purpose of this study is to determine how olive leaf is absorbed and metabolised and also whether it has any effect on vascular function and cytokine concentrations.

Enrollment

18 patients

Sex

All

Ages

19 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 19-40 years, non-smokers, able to swallow capsules, have a Body Mass Index (BMI) of 18.5-30, have a normal liver function and haematology and a max alcohol intake of <21 units/week

Exclusion criteria

  • Those who suffer from any form of disease, including endocrine disease, liver disease, diabetes mellitus, myocardial infarction, blood clotting disorder, reproductive disorder, gastrointestinal disease or a chronic gastrointestinal disorder.
  • Individuals who are vegetarian, have dietary restrictions or on a weight reducing diet will not be recruited.
  • Subjects who have been taking antibiotics in previous 3 months before study will not be included in the study
  • Females who may be pregnant, or if of childbearing potential and are not using effective contraceptive precautions will be excluded.
  • Blood pressure > 150/90 mmHg
  • Haemoglobin < 125 g/l for male, < 110 g/l for female
  • Gamma GT (liver enzymes) > 80 IU/l
  • Cholesterol > 6.5 mmol/l
  • Had suffered a myocardial infarction or stroke in the previous 12 months
  • On any lipid-modifying medication
  • On any medication affecting blood clotting
  • Individuals taking vitamin and/or fish oil supplements

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

18 participants in 2 patient groups, including a placebo group

Placebo capsule
Placebo Comparator group
Description:
Four placebo capsules containing safflower oil only
Treatment:
Dietary Supplement: Olive leaf extract capsules
Olive leaf extract capsule
Active Comparator group
Description:
Four olive leaf capsules. Each containing 4mg oleuropein plus safflower oil.
Treatment:
Dietary Supplement: Olive leaf extract capsules

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems